Bringing a prophylactic Ebola vaccine to licensure

Informations projet

EBOVAC3

N° de convention de subvention: 800176

DOI 10.3030/800176

Date de signature de la CE 15 Juin 2018

Date de début 1 Juin 2018

Date de fin 30 Septembre 2024

Financé au titre de

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coût total € 50 979 889,71

Contribution de l’UE € 29 402 655,71

Coordonné par

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
United Kingdom

Livrables

Documents, reports (1)

Pilot on integrated solution linking vaccine label to biometric profile

Publications

Other (4)

Safety and immunogenicity of the heterologous two-dose Ad26.ZEBOV, MVA-BN-Filo vaccine regimen in healthcare providers and frontliners of the Democratic Republic of the Congo.

Auteurs: Y Larivière, I Garcia-Fogeda, T Zola Matuvanga et al.
Publié dans: 2023
Éditeur: UAntwerp / UNIKIN
DOI: 10.1093/infdis/jiad350

Parameter estimation in nonlinear mixed effect models based on ordinary differential equations: An optimal control approach

Auteurs: Clairon, Quentin; Pasin, Chloé; Balelli, Irene; Thiébaut, Rodolphe; Prague, Mélanie
Publié dans: HAL Open Science, Numéro 1, 2021
Éditeur: HAL Open Science
DOI: 10.13140/rg.2.2.18016.81920

Researchers’ responsibility in low-resource settings: experiences of an ancillary care policy and practices in a vaccine trial in the Democratic Republic of the Congo

Auteurs: Gwen Lemey, T Zola Matuvanga, Ynke Larivière, Solange Milolo, Engbu Danoff, Lazarre Bakonga, Emmanuel Esanga, Peter Vermeiren, Vivi Maketa, Junior Matangila, Patrick Mitashi, Pierre Van Damme, Jean-Pierre Van geertruyden , Raffaella Ravinetto, Hypolite Muhindo-Mavoko
Publié dans: Research Ethics, 2023
Éditeur: UAntwerp
DOI: 10.1177/1747016123119413

Rapport final Etude de la résurgence de la Maladie à Virus Ébola dans la région de Nzérékoré par l’équipe du CERFIG-RKI-IRD-UNICEF

Auteurs: Saez, Almudena Mari, Frederic Le Marcis et al.
Publié dans: 2021
Éditeur: Institute of Research for Development
DOI: 10.13140/rg.2.2.14143.84641

Peer reviewed articles (6)

Setting up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned

Auteurs: Trésor Zola Matuvanga, Ynke Larivière, Gwen Lemey, Jessie De Bie , Solange Milolo, Rachel Meta, Emmanuel Esanga, Paul Peter Vermeiren , Séverine Thys, Jean-Pierre Van geertruyden , Pierre Van Damme, Vivi Maketa, Junior Matangila , Patrick Mitashi, Hypolite Muhindo-Mavoko
Publié dans: Vaccine, 2022, ISSN 0264-410X
Éditeur: Elsevier BV
DOI: 10.1016/j.vaccine.2022.04.094

Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study

Auteurs: Zola Matuvanga T, Johnson G, Larivière Y, Esanga Longomo E, Matangila J, Maketa V, Lapika B, Mitashi P, Mc Kenna P, De Bie J, Van Geertruyden J, Van Damme P, Muhindo Mavoko H.
Publié dans: Journal of Medical Internet Research, Numéro 14388871, 2021, ISSN 1438-8871
Éditeur: Journal of medical Internet Research
DOI: 10.2196/28573

Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo

Auteurs: Lemey, Gwen, Ynke Larivière, Trésor Zola, Hypolite Muhindo, Vivi Maketa, Patrick Mitashi, Junior Matangila, Peter Vermeiren, Jessie De Bie, Jean-Pierre Van geertruyden, Pierre Van Damme
Publié dans: BMJ Global Health, 2021, ISSN 2059-7908
Éditeur: BMJ Global Health
DOI: 10.1136/bmjgh-2021-005726

Resurgence of Ebola Virus in 2021 in Guinea Suggests a New Paradigm for Outbreaks

Auteurs: Keita, Alpha Kabinet, Fara R. Koundouno, Martin Faye, Ariane Düx, Julia Hinzmann, Haby Diallo, Ahidjo Ayouba, Le Marcis, Frédéric et al. 2021.
Publié dans: Nature, 2021, ISSN 1476-4687
Éditeur: Nature
DOI: 10.1038/s41586-021-03901-9

Potential Test-Negative Design Study Bias in Outbreak Settings: Application to Ebola vaccination in Democratic Republic of Congo

Auteurs: Carl B Pearson, W John Edmunds, Thomas J Hladish, Rosalind M Eggo
Publié dans: International Journal of Epidemiology, 2022, ISSN 0300-5771
Éditeur: Oxford University Press
DOI: 10.1093/ije/dyab172

Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol

Auteurs: Ynke Larivière, Trésor Zola, Elke Stoppie, Vivi Maketa, Junior Matangila, Patrick Mitashi, Jessie De Bie, Hypolite Muhindo, Jean-Pierre Van geertruyden, Pierre Van Damme
Publié dans: BMJ Open, 2021, ISSN 2044-6055
Éditeur: BMJ Publishing Group
DOI: 10.1136/bmjopen-2020-046835